NEW YORK (GenomeWeb News) – Silicon Valley Biosystems and the Mayo Clinic announced late on Monday a deal aimed at improving "accessibility and clinical utility of next-generation sequencing for patients."

The deal brings together SV Bio's genome interpretation tools and Mayo's genome reference library. Under its terms, SV Bio will provide clinical genome interpretation services and clinical decision support interfaces to Mayo. Mayo's Center for Individualized Medicine will provide clinical and laboratory expertise and support.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.